Skip to main content

Table 3 Correlations of connexin and Ki67 proliferation marker expression with clinicipathological parameters

From: The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer

 

Cx43

Cx26

Cx32

Cx46

Ki67

 

pre

post

pre

post

pre

post

pre

post

pre

post

ER pre

0.30

x

ns

x

ns

x

ns

x

−0.46

−0.35

ER post

0.36

ns

ns

ns

ns

ns

ns

ns

−0.40

−0.38

PR pre

0.34

x

ns

x

ns

x

ns

x

−0.45

x

PR post

0.33

ns

ns

ns

ns

ns

ns

ns

−0.52

ns

HER2 pre

−0.27

x

ns

x

0.31

x

ns

x

ns

x

HER2 post

ns

ns

ns

ns

ns

ns

ns

ns

ns

0.26

cT pre

0.29

x

ns

x

ns

x

ns

x

ns

x

cN pre

ns

x

ns

x

ns

x

ns

x

ns

x

pT post

ns

ns

ns

ns

−0.29

ns

ns

ns

ns

ns

pN post

ns

ns

ns

ns

ns

ns

0.39

0.32

ns

ns

grade pre

ns

x

ns

x

ns

x

ns

x

ns

ns

Ki67 pre

ns

x

ns

x

ns

x

−0.29

x

x

0.46

Ki67 post

ns

ns

ns

ns

ns

0.46

ns

ns

0.46

x

  1. ns: not significant; x: not relevant; pre: prior to chemotherapy; post: after chemotherapy.